In July of 2021, the Supreme Court in Ruan v the United States ruled that the Government must prove the defendant knowingly or intentionally acted in an unauthorized manner to find them guilty of unauthorized distribution of controlled substances. One year later, authorized prescribers need to know how this standard is being applied in practice to adopt their behaviors accordingly. In this session, topics of discussion include:

• Understanding the guidance released by HHS following the Ruan and Khan cases
• Adapting prescribing practices and procedures based on the outcome
• How is Ruan informing DOJ charging decisions, and what that means for your compliance program moving forward